"Hypnotics and Sedatives" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety.
| Descriptor ID |
D006993
|
| MeSH Number(s) |
D27.505.696.277.350 D27.505.954.427.210.350
|
| Concept/Terms |
Hypnotic Effect- Hypnotic Effect
- Effect, Hypnotic
- Hypnotic Effects
- Effects, Hypnotic
Sedative Effect- Sedative Effect
- Effect, Sedative
- Sedative Effects
- Effects, Sedative
|
Below are MeSH descriptors whose meaning is more general than "Hypnotics and Sedatives".
Below are MeSH descriptors whose meaning is more specific than "Hypnotics and Sedatives".
This graph shows the total number of publications written about "Hypnotics and Sedatives" by people in this website by year, and whether "Hypnotics and Sedatives" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 3 | 1 | 4 |
| 1997 | 1 | 0 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 2 | 0 | 2 |
| 2000 | 5 | 0 | 5 |
| 2001 | 1 | 1 | 2 |
| 2002 | 2 | 1 | 3 |
| 2003 | 3 | 0 | 3 |
| 2004 | 6 | 4 | 10 |
| 2005 | 1 | 1 | 2 |
| 2006 | 5 | 2 | 7 |
| 2007 | 2 | 4 | 6 |
| 2008 | 3 | 0 | 3 |
| 2009 | 2 | 1 | 3 |
| 2010 | 5 | 1 | 6 |
| 2011 | 2 | 1 | 3 |
| 2012 | 2 | 0 | 2 |
| 2013 | 3 | 4 | 7 |
| 2014 | 6 | 3 | 9 |
| 2015 | 4 | 2 | 6 |
| 2016 | 2 | 3 | 5 |
| 2017 | 3 | 4 | 7 |
| 2018 | 8 | 3 | 11 |
| 2019 | 2 | 2 | 4 |
| 2020 | 4 | 0 | 4 |
| 2021 | 0 | 1 | 1 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 4 | 4 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hypnotics and Sedatives" by people in Profiles.
-
Solanki PK, Yellapragada S, Lynch B, Eibel M, Viscusi ER, Emerick T. Emergence of xylazine as a public health threat: what does the anesthesiologist need to know for perioperative care? Reg Anesth Pain Med. 2025 01 07; 50(1):55-58.
-
Philip AB, Brohan J, Goudra B. The Role of GABA Receptors in Anesthesia and Sedation: An Updated Review. CNS Drugs. 2025 01; 39(1):39-54.
-
Perrone J, Haroz R, D'Orazio J, Gianotti G, Love J, Salzman M, Lowenstein M, Thakrar A, Klipp S, Rae L, Reed MK, Sisco E, Wightman R, Nelson LS. National Institute on Drug Abuse Clinical Trials Network Meeting Report: Managing Patients Exposed to Xylazine-Adulterated Opioids in Emergency, Hospital and Addiction Care Settings. Ann Emerg Med. 2024 07; 84(1):20-28.
-
Bowles JM, Copulsky EC, Reed MK. Media framing xylazine as a "zombie drug" is amplifying stigma onto people who use drugs. Int J Drug Policy. 2024 03; 125:104338.
-
Hagan L, David EM, Horton AR, Marx JO. Effects of Midazolam/Dexmedetomidine with Buprenorphine or Extended-release Buprenorphine Anesthesia in C57BL/6 Mice. J Am Assoc Lab Anim Sci. 2024 03 01; 63(2):172-181.
-
Wyler D, Torjman MC, Leong R, Baram M, Denk W, Long SC, Gawel RJ, Viscusi ER, Wainer IW, Schwenk ES. Observational study of the effect of ketamine infusions on sedation depth, inflammation, and clinical outcomes in mechanically ventilated patients with SARS-CoV-2. Anaesth Intensive Care. 2024 Mar; 52(2):105-112.
-
Kacinko SL, Mohr ALA, Logan BK, Barbieri EJ. Xylazine: Pharmacology Review and Prevalence and Drug Combinations in Forensic Toxicology Casework. J Anal Toxicol. 2022 Oct 14; 46(8):911-917.
-
Hozack BA, Kistler JM, Vaccaro AR, Beredjiklian PK. Benzodiazepines and Related Drugs in Orthopaedics. J Bone Joint Surg Am. 2022 12 21; 104(24):2204-2210.
-
Huyett P, Kent DT, D'Agostino MA, Green KK, Soose RJ, Kaffenberger TM, Woodson BT, Huntley C, Boon MS, Heiser C, Birk A, Suurna MV, Lin HS, Waxman JA, Kezirian EJ. Drug-Induced Sleep Endoscopy and Hypoglossal Nerve Stimulation Outcomes: A Multicenter Cohort Study. Laryngoscope. 2021 07; 131(7):1676-1682.
-
Wilt ZT, Tan TL, Rondon AJ, Wang WL, Foltz C, Beredjiklian PK, Arnold WV. Preoperative Sedative Use and Other Risk Factors for Continued Narcotic Use After Total Knee Arthroplasty: A Comprehensive Analysis of a Mandatory Database. Orthopedics. 2021 Jan 01; 44(1):e50-e54.